Fosrolapitant and Palonosetron Hydrochloride for Injection

DRUG2 trials

Sponsors

Shanghai 6th People's Hospital, Tianjin Medical University Cancer Institute and Hospital

Conditions

Chemotherapy-Induced Nausea and Vomiting (CINV)Chemotherapy-induced Nausea and Vomiting

Phase 2

Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV

RecruitingNCT07726433

Tianjin Medical University Cancer Institute and HospitalChemotherapy-Induced Nausea and Vomiting (CINV)

Start: 2026-06-15End: 2028-06-01Target: 56Updated: 2026-07-24

Phase 4

An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC

RecruitingNCT07482891

Shanghai 6th People's HospitalChemotherapy-induced Nausea and Vomiting

Start: 2026-03-10End: 2026-12-31Target: 200Updated: 2026-04-30